Further investigation of genomic variations demonstrated high-frequency SNVs and CNVs in key regulators such as PTEN, ARID1A, and UBR4, particularly in endometrial cancer, where PTEN and ARID1A mutations were significantly enriched. Here, UBR4 is linked to endometrial cancer.